When is off-label off-road? von de Vries, E.G.E., Cherny, N.I., Voest, E.E.

Volltext

When is off-label off-road? von de Vries, E.G.E., Cherny, N.I., Voest, E.E.

Volltext

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic von de Groot, D.J.A, de Vries, E.G.E, Groen, H.J.M, de Jong, S

Volltext

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate von Garassino, M.C., Vyas, M., de Vries, E.G.E., Kanesvaran, R., Giuliani, R., Peters, S.

Volltext

TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives von Stegehuis, J.H, de Wilt, L.H.A.M, de Vries, E.G.E, Groen, H.J, de Jong, S, Kruyt, F.A.E

Volltext

Rectal and colon cancer: Not just a different anatomic site von Tamas, K, Walenkamp, A.M.E, de Vries, E.G.E, van Vugt, M.A.T.M, Beets-Tan, R.G, van Etten, B, de Groot, D.J.A, Hospers, G.A.P

Volltext

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR tria... von Gebhart, G., Lamberts, L.E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Oyen, W.J.G., Vugts, D.J., Hoekstra, O.S., Schröder, C.P., Menke-van der Houven van Oordt, C.W., Guiot, T., Brouwers, A.H., Awada, A., de Vries, E.G.E., Flamen, P.

Volltext

MEIS and PBX homeobox proteins in ovarian cancer von Crijns, A.P.G, de Graeff, P, Geerts, D, ten Hoor, K.A, Hollema, H, van der Sluis, T, Hofstra, R.M.W, de Bock, G.H, de Jong, S, van der Zee, A.G.J, de Vries, E.G.E

Volltext

Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort von Mom, C.H, Engelen, M.J.A, Willemse, P.H.B, Gietema, J.A, ten Hoor, K.A, de Vries, E.G.E, van der Zee, A.G.J

Volltext

Prognostic versus predictive value of biomarkers in oncology von Oldenhuis, C.N.A.M, Oosting, S.F, Gietema, J.A, de Vries, E.G.E

Volltext

Functional genomic mRNA (FGmRNA) profiling of > 18,000 tumor samples identifies potential new indications for antibody-drug conjugates (ADCs) in a broad range of tumor types von Moek, K.L., de Groot, D.J., de Vries, E.G.E., Fehrmann, R.S.N.

Volltext

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients von Vollebergh, M.A., Lips, E.H., Nederlof, P.M., Wessels, L.F.A., Schmidt, M.K., van Beers, E.H., Cornelissen, S., Holtkamp, M., Froklage, F.E., de Vries, E.G.E., Schrama, J.G., Wesseling, J., van de Vijver, M.J., van Tinteren, H., de Bruin, M., Hauptmann, M., Rodenhuis, S., Linn, S.C.

Volltext

The antibody–drug conjugate target landscape across a broad range of tumour types von Moek, K.L., de Groot, D.J.A., de Vries, E.G.E., Fehrmann, R.S.N.

Volltext

Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer von Engelen, M.J.A, Snel, B.J, Schaapveld, M, Pras, E, de Vries, E.G.E, Gietema, J.A, van der Zee, A.G.J, Willemse, P.H.B

Volltext

Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect von Ariaans, G, de Jong, S, Gietema, J.A, Lefrandt, J.D, de Vries, E.G.E, Jalving, M

Volltext

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncol... von Cherny, N.I., Sullivan, R., Dafni, U., Kerst, J.M., Sobrero, A., Zielinski, C., de Vries, E.G.E., Piccart, M.J.

Volltext

535 Tumor targeting and tissue distribution of solitomab (AMG 110; anti-EpCAM BiTE®) in human EpCAM-positive tumor bearing mice von Warnders, F.J, Waaijer, S, Lub-de Hooge, M.N, Friedrich, M, van Scheltinga, A.G.T. Terwisscha, Deegen, P, Stienen, S.K, Pieslor, P.C, Cheung, H.K, Kosterink, J.G.W, de Vries, E.G.E

Volltext

A potential role of macrophage activation in the treatment of cancer von Klimp, A.H., de Vries, E.G.E., Scherphof, G.L., Daemen, T.

Volltext

Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer von Altena, R., Hummel, Y.M., Nuver, J., Smit, A.J., Lefrandt, J.D., de Boer, R.A., Voors, A.A., van den Berg, M.P., de Vries, E.G.E., Boezen, H.M., Gietema, J.A.

Volltext

Balancing treatment efficacy, toxicity and complication risk in elderly patients with metastatic renal cell carcinoma von van den Brom, R.R.H, van Es, S.C, Leliveld, A.M, Gietema, J.A, Hospers, G.A.P, de Jong, I.J, de Vries, E.G.E, Oosting, S.F

Volltext